MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Hyperpolarization of the subthalamic nucleus alleviates hyperkinetic movement disorders

    C.H Tai, S.H Tseng, T.R Wang, M.T Hsu, C-C. Kuo (Taipei, Taiwan)

  • Hyposmia as a biomarker in patients with Parkinson’s disease and atypical Parkinsonism

    S. Kumaran, A. Ankeeta, S. Chaudhary, P. Bhat, V. Goyal (New Delhi, India)

  • Identification and characterization of anti-prionic compounds that disassemble Tau prions as a novel therapeutic approach for tauopathies

    D. Willbold, T. Altendorf, W. Hoyer, J. Mohrlüder (Jülich, Germany)

  • Identification and characterization of anti-prionic compounds that disassemble αSyn prions as a novel therapeutic approach for synucleinopathies

    D. Willbold, M. Sevenich, W. Hoyer, J. Mohrlüder, A. Willuweit (Jülich, Germany)

  • Identification and clinical characteristics of Mild Cognitive Impairment in Parkinson’s disease

    J. Yang, E. Forbes, D. Pourzinal, K. McMahon, D. Copland, G. Byrne, J. O'Sullivan, L. Mitchell, N. Dissanayaka (Herston, Australia)

  • Identification and Documentation of Delirium in Parkinson’s Disease

    R. Cullinan, S. Richardson, A. Yarnall, D. Burn, L. Allan, R. Lawson (Newcastle-Upon-Tyne, United Kingdom)

  • Identification of a novel XK mutation in a Chinese patient with McLeod Syndrome

    J. Ma, Y.M Liu (Jinan, China)

  • Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE

    A. Esquenazi, W. Feng, G. Wittenberg, P. Gallien, A. Baricich, K. Fanning, A. Zuzek, G. Francisco, D. Bandari (Elkins Park, PA, USA)

  • Identification of Parkinson’s disease predisposition genes in high-risk pedigrees

    P. Moretti, K. Figueroa, S. Pulst, L. Cannon-Albright (Salt Lake City, UT, USA)

  • Identifying biomarkers to predict disease progression in early stage Parkinson’s disease patients

    L. Neilson, J. Baird, B. Lobb, H. Vanderjagt, N. Gray, S. O'Connor, J. Quinn (Portland, OR, USA)

  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 149
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley